Zooming in and Out of Programmed Cell Death in Osteoarthritis: A Scientometric and Visualized Analysis

J Inflamm Res. 2024 Apr 23:17:2479-2498. doi: 10.2147/JIR.S462722. eCollection 2024.

Abstract

During the past decade, mounting evidence has increasingly linked programmed cell death (PCD) to the progression and development of osteoarthritis (OA). There is a significant need for a thorough scientometric analysis that recapitulates the relationship between PCD and OA. This study aimed to collect articles and reviews focusing on PCD in OA, extracting data from January 1st, 2013, to October 31st, 2023, using the Web of Science. Various tools, including VOSviewer, CiteSpace, Pajek, Scimago Graphica, and the R package, were employed for scientometric and visualization analyses. Notably, China, the USA, and South Korea emerged as major contributors, collectively responsible for more than 85% of published papers and significantly influencing research in this field. Among different institutions, Shanghai Jiao Tong University, Xi'an Jiao Tong University, and Zhejiang University exhibited the highest productivity. Prolific authors included Wang Wei, Wang Jing, and Zhang Li. Osteoarthritis and Cartilage had the most publications in this area. Keywords related to PCD in OA prominently highlighted 'chondrocytes', 'inflammation', and 'oxidative stress', recognized as pivotal mechanisms contributing to PCD within OA. This study presents the first comprehensive scientometric analysis, offering a broad perspective on the knowledge framework and evolving patterns concerning PCD in relation to OA over the last decade. Such insights can aid researchers in comprehensively understanding this field and provide valuable directions for future explorations.

Keywords: global scientific frontiers; osteoarthritis; programmed cell death; scientometrics; visualization analysis.

Publication types

  • Review

Grants and funding

Grants for this study were provided by various sources, including the National Natural Science Foundation of China (No. 82172432, 82102568, 82001319), the National & Local Joint Engineering Research Centre of Orthopaedic Biomaterials (No. XMHT20190204007), the Guangdong Basic and Applied Basic Research Foundation (No. 2021A1515012586, 2021A1515220054, 2022B1515120046, 2022A1515220038, 2022A1515220111, 2021A1515220037, 2022A1515220165), the Shenzhen High-Level Hospital Construction Fund, the Shenzhen Key Laboratory of Orthopaedic Diseases and Biomaterials Research (No. ZDSYS20220606100602005), the Shenzhen Key Medical Discipline Construction Fund (No. SZXK023), the Sanming Project of Medicine in Shenzhen (No. SZSM202211038), the Research and Development Projects of Shenzhen (No. JCYJ20210324110214040, JCYJ20220531094214032, JCYJ20190809152409606, JCYJ20210324105806016, JCYJ20220531094406015), the Shenzhen Sustainable Development Project (No. KCXFZ20201221173411031), and the Scientific Research Foundation of Peking University Shenzhen Hospital (No. KYQD2021099).